zolmitriptan / Generic mfg. |
2007-002654-36: A randomised prospective open multi-attack study of patient preference and efficacy between zolmitriptan nasal spray 5 mg and sumatriptan RDT 100 mg in the acute treatment of migraine. |
|
|
| Ongoing | 4 | 100 | Europe | zolmitriptan, sumatriptan, Zomig Nasal, Imigran Novum, Zomig Nasal, Imigran Novum | Carl Dahlöf | Migraine with and without aura (G 43.0 and G 43.1) | | | | |
NCT06089356: Zolmitriptane as Prophylaxis for Chilhood Migraine |
|
|
| Recruiting | 4 | 90 | RoW | zolmitriptanee, zolmitriptane tablet, topiramate, topiramate tablet, Valproate, Valproate tablet | Tanta University | Migraine | 01/24 | 01/24 | | |
ACTRN12620000234910p: An interventional study to assess the safety, pharmacokinetic (PK, the measure of how the human body processes a substance) response and tolerability (how well a substance is tolerated by participants) to Zolmitriptan following multiple oral doses in Adult Healthy Volunteers |
|
|
| Not yet recruiting | 1 | 48 | | | Maplight therapeutics , Maplight therapeutics | Autism | | | | |
NCT06074016: Pharmacokinetics in Oral and Intranasal Formulations of Zolmitriptan. |
|
|
| Completed | 1 | 8 | Europe | Zolmitriptan intranasal., Zolmitriptan oral. | Parc de Salut Mar, Food and Drug Administration (FDA) | Healthy | 09/23 | 09/23 | | |
| Recruiting | 1 | 20 | US | Cocaine, Placebo oral capsule, Zolmitriptan | William Stoops, National Institute on Drug Abuse (NIDA) | Cocaine Use Disorder | 11/25 | 11/25 | | |